Endocrinology, Internal medicine, Pharmacology, Anesthesia and Dopamine are his primary areas of study. The various areas that Gian Luigi Gessa examines in his Endocrinology study include Cannabinoid, Antagonist and Serotonin. Gian Luigi Gessa focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Biochemistry and, in certain cases, Selective breeding and Motor incoordination.
His work deals with themes such as Agonist, Receptor and Naltrexone, which intersect with Pharmacology. His Anesthesia research incorporates themes from Ethanol, Heroin, Alcohol withdrawal syndrome, Abstinence and Baclofen. Electrophysiology is closely connected to Premovement neuronal activity in his research, which is encompassed under the umbrella topic of Dopamine.
Gian Luigi Gessa mostly deals with Internal medicine, Endocrinology, Pharmacology, Dopamine and Ethanol. His Endocrinology research includes elements of Receptor, Biochemistry and Cannabinoid receptor. His Pharmacology study incorporates themes from Agonist, Baclofen, GABAB receptor, Antagonist and Cannabinoid.
Dopamine is a subfield of Neuroscience that Gian Luigi Gessa studies. His biological study spans a wide range of topics, including Alcohol, Anesthesia, gamma-Hydroxybutyric acid and Oral administration. His Anesthesia research is multidisciplinary, relying on both Alcohol withdrawal syndrome and Abstinence.
Gian Luigi Gessa mainly focuses on Pharmacology, Internal medicine, Alcohol, Endocrinology and Agonist. His studies in Pharmacology integrate themes in fields like Cannabinoid, GABAB receptor, Antagonist, Cannabinoid receptor and Baclofen. His Cannabinoid research is multidisciplinary, incorporating elements of Nucleus accumbens and Neuroscience.
His research integrates issues of Ethanol and Self-administration in his study of Alcohol. Endocrinology is frequently linked to Anxiolytic in his study. His work carried out in the field of Agonist brings together such families of science as NMDA receptor, Sedative and Prepulse inhibition.
His primary areas of study are Pharmacology, Alcohol, Cannabinoid, Cannabinoid receptor and Endocrinology. His study looks at the intersection of Pharmacology and topics like Alcohol dependence with -Naloxone. His Alcohol research incorporates elements of Ethanol, Baclofen, GABAB receptor and Self-administration.
Gian Luigi Gessa interconnects Body weight, Nucleus accumbens, Rimonabant and Receptor antagonist in the investigation of issues within Cannabinoid. His biological study spans a wide range of topics, including Internal medicine and Biochemistry. The various areas that Gian Luigi Gessa examines in his Internal medicine study include Alcohol preferring and Cortex.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area.
Gian Luigi Gessa;Francesco Muntoni;Maria Collu;Lidia Vargiu.
Brain Research (1985)
Effects of Moderate Alcohol Consumption on the Central Nervous System
Michael J. Eckardt;Sandra E. File;Gian Luigi Gessa;Kathleen A. Grant.
Alcoholism: Clinical and Experimental Research (1998)
Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats.
Zvani L. Rossetti;Yousef Hmaidan;Gian Luigi Gessa.
European Journal of Pharmacology (1992)
Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
Giancarlo Colombo;Roberta Agabio;Giacomo Diaz;Carla Lobina.
Life Sciences (1998)
Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats
Francesco Marrosu;Chiara Portas;Maria Stefania Mascia;Maria Antonietta Casu.
Brain Research (1995)
Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
Giovanni Addolorato;Fabio Caputo;Esmeralda Capristo;Marco Domenicali.
Alcohol and Alcoholism (2002)
Central functions of oxytocin
Antonio Argiolas;Gian Luigi Gessa.
Neuroscience & Biobehavioral Reviews (1991)
Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors
Miriam Melis;Marco Pistis;Simona Perra;Anna Lisa Muntoni.
The Journal of Neuroscience (2004)
Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence
Marco Diana;Marco Pistis;Susanna Carboni;Gian Luigi Gessa.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet.
Giovanni Biggio;Fabio Fadda;Patrizia Fanni;Alessandro Tagliamonte.
Life Sciences (1974)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: